Anzeige
❌
Mehr »
Freitag, 20.11.2026 - Börsentäglich über 12.000 News
Rund 40 Mio. USD Staatsaufträge bis Juni 2029 gebucht: Jetzt zählt die Marge!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Renaissance Capital

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
29.10.SPAC Redwoods Acquisition II files for a $75 million IPO, targeting energy storage, telecom, and consumer businesses
29.10.Natural pest control maker Med-X increases shares registered by 23% ahead of Nasdaq direct listing
29.10.SPAC BHAV Acquisition II prices $100 million IPO, targeting robotics, fintech, computing, and energy tech
29.10.Georgia Banking Company announces Nasdaq direct listing on October 29
28.10.Singapore-based digital ad network Focus Media Network files for a $25 million US IPO
28.10.IPO Weekly Weigh-in: Anthropic's one share to rule them all
27.10.SPAC Heroic Empire Acquisition files for a $100 million IPO, targeting AI, biotech, energy, and manufacturing
27.10.Regenerative medicine device provider RegenLab USA sets terms for $18 million IPO
27.10.SPAC SPACCircle Acquisition prices $100 million IPO, targeting digital assets, tech, and healthcare
26.10.SPAC Aimei Health Technology II increases unit offering by 67% ahead of $100 million IPO
26.10.Laser-based uranium enrichment developer LIS Technologies files for a $17 million IPO
26.10.AI model developer Anthropic PBC files for an estimated $75 billion IPO, teeing up one of the largest-ever IPOs for mid-November
26.10.Parkinson's disease biotech Aspen Neuroscience sets terms for $150 million IPO
26.10.Immunology and inflammation biotech Bambusa Therapeutics sets terms for $150 million IPO
24.10.US IPO Week Ahead: Africa-focused fintech target's week sole IPO as Anthropic nears its public filing
24.10.US IPO Weekly Recap: Trickle of biotech activity continues amid tech sell-off
24.10.SPAC: BHAV Acquisition II lowers deal size by 33% ahead of $100 million IPO
23.10.Emerging markets fintech OPay sets terms for $320 million US IPO
23.10.Switzerland-based respiratory biotech Windward Bio Group files for a $100 million US IPO
23.10.Lycia Therapeutics prices upsized IPO at $18, the high end of the range
22.10.Inflammatory diseases biotech Rezera files for an estimated $100 million IPO
22.10.Inflammatory diseases biotech Rezera files for a $100 million IPO
21.10.China-based AI vision solutions provider Sensing4D AI files for a $35 million US IPO
21.10.Africa-linked IPOs pick up steam in 2026
20.10.Allergy and autoimmune biotech Lycia Therapeutics sets terms for $250 million IPO